[go: up one dir, main page]

AR048235A1 - Un procedimiento para la sintesis de (7-metoxi-3,4-dihidro-1-naftalenil)acetonitrilo y su aplicacion en la sintesis de agomelatina - Google Patents

Un procedimiento para la sintesis de (7-metoxi-3,4-dihidro-1-naftalenil)acetonitrilo y su aplicacion en la sintesis de agomelatina

Info

Publication number
AR048235A1
AR048235A1 ARP050100499A ARP050100499A AR048235A1 AR 048235 A1 AR048235 A1 AR 048235A1 AR P050100499 A ARP050100499 A AR P050100499A AR P050100499 A ARP050100499 A AR P050100499A AR 048235 A1 AR048235 A1 AR 048235A1
Authority
AR
Argentina
Prior art keywords
synthesis
procedure
naftalenil
agomelatin
metoxi
Prior art date
Application number
ARP050100499A
Other languages
English (en)
Inventor
Jean-Claude Souvie
Blanco Isaac Gonzales
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR048235A1 publication Critical patent/AR048235A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/33Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la síntesis industrial del compuesto de formula 1 y procedimiento para la síntesis de la agomelatina a partir del compuesto de formula 1
ARP050100499A 2004-02-13 2005-02-11 Un procedimiento para la sintesis de (7-metoxi-3,4-dihidro-1-naftalenil)acetonitrilo y su aplicacion en la sintesis de agomelatina AR048235A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0401436A FR2866336B1 (fr) 2004-02-13 2004-02-13 Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
AR048235A1 true AR048235A1 (es) 2006-04-12

Family

ID=34685016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100499A AR048235A1 (es) 2004-02-13 2005-02-11 Un procedimiento para la sintesis de (7-metoxi-3,4-dihidro-1-naftalenil)acetonitrilo y su aplicacion en la sintesis de agomelatina

Country Status (32)

Country Link
US (1) US7479569B2 (es)
EP (1) EP1564204B1 (es)
JP (1) JP4192155B2 (es)
KR (1) KR100682699B1 (es)
CN (1) CN1293048C (es)
AR (1) AR048235A1 (es)
AT (1) ATE382603T1 (es)
AU (1) AU2005200618B8 (es)
BR (1) BRPI0501093B1 (es)
CA (1) CA2495628C (es)
CY (1) CY1107156T1 (es)
DE (1) DE602005004044T2 (es)
DK (1) DK1564204T3 (es)
EA (1) EA007795B1 (es)
ES (1) ES2298964T3 (es)
FR (1) FR2866336B1 (es)
GE (1) GEP20063955B (es)
HR (1) HRP20080134T3 (es)
MA (1) MA27515A1 (es)
ME (1) ME01401B (es)
MX (1) MXPA05001632A (es)
MY (1) MY143266A (es)
NO (1) NO333483B1 (es)
NZ (1) NZ538194A (es)
PL (1) PL1564204T3 (es)
PT (1) PT1564204E (es)
RS (1) RS50545B (es)
SG (1) SG114704A1 (es)
SI (1) SI1564204T1 (es)
UA (1) UA76649C2 (es)
WO (1) WO2005077888A1 (es)
ZA (1) ZA200501254B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154140A2 (en) 2010-06-10 2011-12-15 Gador S.A. New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide and new crystalline form

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866334B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
FR2889522B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889523B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889521B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
WO2007079317A2 (en) * 2005-12-06 2007-07-12 Neurocrine Biosciences, Inc. Use of sedative hypnotics for treating obesity or maintaining weight loss
CN101638376B (zh) * 2008-07-29 2011-04-27 江苏恩华药业股份有限公司 阿戈美拉汀的制备方法及其中间体
CN102276492B (zh) * 2010-06-08 2013-04-10 上海医药工业研究院 阿戈美拉汀中间体及其制备方法
CN102060733B (zh) * 2010-12-06 2014-01-29 威海迪素制药有限公司 (7-甲氧基-3,4-二氢-1-萘基)乙腈的制备方法
WO2013054273A2 (en) 2011-10-11 2013-04-18 Ranbaxy Laboratories Limited Process for the preparation of agomelatine
EP2785681A1 (en) 2011-12-01 2014-10-08 Ranbaxy Laboratories Limited Process for the preparation of agomelatine
WO2014001939A1 (en) * 2012-06-30 2014-01-03 Alembic Pharmaceuticals Limited Process for preparation of agomelatine and crystalline form i thereof
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US432702A (en) * 1890-07-22 Car-seat
US3931188A (en) * 1974-05-06 1976-01-06 Bristol-Myers Company 3-Hydroxy-5,6-benzomorphinan derivatives
US3992403A (en) * 1975-05-30 1976-11-16 Schering Corporation 2-Imidazolines and their use as hypoglycemic agents
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866334B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154140A2 (en) 2010-06-10 2011-12-15 Gador S.A. New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide and new crystalline form

Also Published As

Publication number Publication date
AU2005200618A1 (en) 2005-09-01
US7479569B2 (en) 2009-01-20
FR2866336A1 (fr) 2005-08-19
SG114704A1 (en) 2005-09-28
ZA200501254B (en) 2005-11-30
CY1107156T1 (el) 2012-10-24
HRP20080134T3 (en) 2008-05-31
AU2005200618A8 (en) 2011-06-02
CA2495628A1 (fr) 2005-08-13
NZ538194A (en) 2006-01-27
HK1078565A1 (en) 2006-03-17
EP1564204B1 (fr) 2008-01-02
DK1564204T3 (da) 2008-05-13
EP1564204A1 (fr) 2005-08-17
BRPI0501093A (pt) 2005-11-16
ES2298964T3 (es) 2008-05-16
PT1564204E (pt) 2008-01-29
CA2495628C (fr) 2007-11-27
UA76649C2 (en) 2006-08-15
JP2005239716A (ja) 2005-09-08
BRPI0501093B1 (pt) 2018-07-10
RS50545B (sr) 2010-05-07
WO2005077888A1 (fr) 2005-08-25
EA200500202A1 (ru) 2005-08-25
JP4192155B2 (ja) 2008-12-03
FR2866336B1 (fr) 2006-03-24
NO333483B1 (no) 2013-06-24
MY143266A (en) 2011-04-15
ATE382603T1 (de) 2008-01-15
KR20060041904A (ko) 2006-05-12
PL1564204T3 (pl) 2008-03-31
SI1564204T1 (sl) 2008-04-30
KR100682699B1 (ko) 2007-02-15
US20050182268A1 (en) 2005-08-18
MA27515A1 (fr) 2005-09-01
AU2005200618B8 (en) 2011-06-02
NO20050738D0 (no) 2005-02-11
MXPA05001632A (es) 2005-08-19
GEP20063955B (en) 2006-10-25
EA007795B1 (ru) 2007-02-27
AU2005200618B2 (en) 2011-05-19
DE602005004044D1 (de) 2008-02-14
NO20050738L (no) 2005-08-15
CN1680295A (zh) 2005-10-12
DE602005004044T2 (de) 2009-01-15
ME01401B (me) 2010-05-07
CN1293048C (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
BR122018068717B8 (pt) processos para a síntese de agomelatina
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
CR10157A (es) Compuestos químicos
CY1109737T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης
MX2007005933A (es) Compuestos de acetamida como fungicidas.
EA201100689A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
TW200728280A (en) Anthracene derivative
MY160226A (en) New process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and application in the synthesis of agomelatine
CY1107156T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-3,4-διυδρο-1-ναφθαλινυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
CY1111081T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγκομελατινης
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
EP1813596A4 (en) PROCESS FOR PREPARING ALPHA, ALPHA-DIFLUORAMINE
EA200802273A1 (ru) Нейропротективные соединения и их применение
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
UY28145A1 (es) Nuevos compuestos farmaceuticos
DE60321724D1 (de) 1,2-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung

Legal Events

Date Code Title Description
FB Suspension of granting procedure